Incyte
INCY
#1110
Rank
S$26.08 B
Marketcap
S$132.86
Share price
2.05%
Change (1 day)
32.48%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of September 2025 : S$8.20 Billion

According to Incyte's latest financial reports the company's total assets are S$8.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$7.40 B-17.38%
2023-12-31S$8.95 B14.39%
2022-12-31S$7.83 B17.41%
2021-12-31S$6.66 B41.58%
2020-12-31S$4.71 B1.97%
2019-12-31S$4.61 B27.81%
2018-12-31S$3.61 B17.37%
2017-12-31S$3.07 B29.86%
2016-12-31S$2.37 B66.42%
2015-12-31S$1.42 B35.41%
2014-12-31S$1.05 B31.94%
2013-12-31S$0.79 B97.4%
2012-12-31S$0.40 B-5.15%
2011-12-31S$0.42 B-32.45%
2010-12-31S$0.63 B-36.94%
2009-12-31S$1.00 B200.94%
2008-12-31S$0.33 B-16.23%
2007-12-31S$0.39 B-26.83%
2006-12-31S$0.54 B-12.95%
2005-12-31S$0.62 B-26.14%
2004-12-31S$0.84 B30.78%
2003-12-31S$0.64 B-32.69%
2002-12-31S$0.95 B-26.65%
2001-12-31S$1.30 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
S$116.81 B 1,323.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.91 B-76.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$148.94 B 1,715.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 3,197.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.73 B-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.63 B-92.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$139.03 B 1,594.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
S$0.13 B-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$0.14 B-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA